News

News
Novel Drug Combination Improves Outcomes in Patients With Early Breast Cancer
A study found when ribociclib, a targeted therapy drug, is added to hormone therapy there are a significant invasive disease-free survival benefit in patients with early hormone-receptor (HR) positive/HER2 negative breast cancer.

News
Clinical Trial Shows Newly Approved Drug's Potential for Rare B-Cell Lymphoma
Results of a trial of pirtobrutinib highlight the drug’s impact and potential for pre-treated mantle cell lymphomas.

News
Eye Drops Slow Kids’ Nearsightedness Progression in Clinical Trial
Clinical trial suggests low-dose atropine is effective myopia treatment.

News
Parkinson’s Drug Slows ALS Progression in Small Clinical Trial
Results from a small clinical trial show that the Parkinson’s disease drug ropinirole delayed the progression of amyotrophic lateral sclerosis (ALS) by an average of 27.9 weeks.

News
Novel Antibiotics Offer an Alternative to Fighting Resistant Bacteria
Researchers have now modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in the bacteria’s metabolism.

News
Artificial Sweetener Metabolite Breaks DNA
Scientists at the North Carolina State University found that a chemical compound produced through the digestion of a common artificial sweetener causes damage to DNA.

News
"Molecular Editing" Technique Aids Crafting of Pharmaceuticals and Other Compounds
Researchers add another powerful tool to their “molecular editing” kit for crafting pharmaceuticals and other valuable compounds, enabling chemists to add new elements to organic molecules at locations that were previously out of reach.

News
Medication Vial Changes Color When It Gets Too Warm
A brightly colored microcrystal that loses its color over time depending on temperature could be used to identify whether a vial of medicine has gotten too warm.

News
New Cancer Immunotherapy Approach Improves Efficacy and Side Effects in Mice
Scientists have discovered a novel approach that improves the efficacy of immune checkpoint inhibitor cancer treatment and minimizes the associated side effects.

News
Genetic Cause of Rare Skin Disorder Identified
The genetic variants that cause a rare and inflammatory skin condition have been identified, alongside a potential treatment.
Advertisement